Logout Login Cart iconShop Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "2025年10月28日龙虎榜,2025年10月28日收盘跌幅>5,非ST,非退市,非新股,非创业板,非科创板,非北证"

Looking for quality documents?
store icon
SIUS PD 0.02m2 (LP) HyS 5kD Cassette – Repligen
SIUS PD cassette with HyStream 5kD L: medium channel; single-use/reusable 0.02m2  holder-L Product Specifications Part Number: XP005LP2L Membrane Type  MWCO Membrane Area (m2) Channel Type  Holder Config. HyStream 5 kD 0.02m2  L L
store icon
SIUS PD 0.1m2 (LP) HyS 5kD Cassette – Repligen
SIUS PD cassette with HyStream 5kD L: medium channel; single-use/reusable 0.1m2  holder-L Product Specifications Part Number: XP005L01L Membrane Type  MWCO Membrane Area (m2) Channel Type  Holder Config. HyStream 5 kD 0.1m2  L L
publications icon
KB16008 SoloVPE Software V3 Security Configuration Article
external link icon
Repligen Corporation to Present at Upcoming May Investor Conferences
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences.
RBC Capital Markets’ 2024 Global Healthcare Conference, being held in New York on May 14-15. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 14, 2024 at 10:30 a.m. ET, in addition to a series of one-on-one meetings with investors. Craig-Hallum’s 21 st Annual Institutional Investor Conference, being held in Minneapolis on May 29. Jason K. Garland, Chief Financial officer will participate in a series of one-on-one meetings with investors. Leerink Partners’ 2024 Healthcare Crossroads Conference, being held in Austin, Texas on May 28-29. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 30, 2024 at 8:40 a.m. CT, in addition to a
external link icon
Repligen Corporation to Present at Upcoming May Investor Conferences
WALTHAM, Mass., May 07, 2025 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2025 Global Healthcare Conference, being held in New York on May 20-21. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 20 at 3:35 p.m. ET, in addition to a series of one-on-one meetings with investors. Craig-Hallum’s 22 nd Annual Institutional Investor Conference, being held in Minneapolis on May 28. Jason K. Garland, Chief Financial Officer will participate in a series of one-on-one meetings with investors. A live webcast of the RBC conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com , and will be available for replay for a limited period of time following the event. About Repligen Corporation
Repligen
external link icon
Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth quarter revenue of $168 million and full year revenue of $634 million Fourth quarter orders and revenues sequentially increased 11% and 8% respectively Orders outpaced revenue by 6% in the fourth quarter Provides full year 2025 guidance of 8% to 12% reported growth and 10% to 14% excluding COVID-related revenue WALTHAM, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter of 2024, covering the three- and twelve-month periods ended December 31, 2024. The company is also providing financial guidance for the full year 2025. Olivier Loeillot, President and Chief Executive Officer of Repligen said, “During the fourth quarter, we were very encouraged by the continued momentum across our portfolio. Total revenue in the fourth quarter grew 13% excluding COVID, overcoming two points of currency headwind. Total orders outpaced sales by 6%,
external link icon
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming investor conferences. The UBS Global Healthcare Conference, being held November 10 – 12 in Palm Beach Gardens, FL. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 11:00 a.m. ET on Monday, November 10. The Stifel Healthcare Conference, being held November 11 – 13 in New York. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion at 10:00 a.m. ET on Tuesday, November 11. The Wolfe Research Healthcare Conference, being held November 17 – 19 in New York. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 12:40 p.m. ET on Tuesday, November 18. The Jefferies Global Healthcare Conference, being held November 18 – 20 in London, UK. Olivier Loeillot,